GlassScriptPhysician profile
Joshua Simon
NPI 1356766554
$17,389.59
in general payments reported to CMS, 2019-2025
31 companies · $598 in 2025
The $598 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $194 · 2020: $66.61 · 2021: $13K · 2022: $1,973 · 2023: $555 · 2024: $708 · 2025: $598.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,841 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,841.38 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $14,140.84 | 2021-2023 | Da Vinci Surgical System |
| Tela Bio, INC. | $1,358.91 | 2021-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Davol INC. | $209.51 | 2022-2023 | Phasix Mesh |
| Aroa Biosurgery Incorporated | $193.89 | 2022-2024 | |
| Atricure, INC. | $185.68 | 2024 | |
| Abbvie INC. | $133.43 | 2021-2022 | |
| Depuy Synthes Sales INC. | $130.41 | 2025 | Na |
| Smith+Nephew, INC. | $98.39 | 2019-2025 | Collagenase Santyl, Grafix Pl |
| Integra Lifesciences Corporation | $94.30 | 2021-2025 | Integra, Surgimend, Integra Dermal Regeneration Template |
| Lexington Medical, INC. | $86.22 | 2025 | Aeon Endostapler & Echelon Flex Powered Stapler |
| Medical Device Business Services, INC. | $85.94 | 2020-2024 | Matrixrib |
| Acera Surgical, INC. | $76.79 | 2023-2025 | Restrata Wound Matrix |
| Cumberland Pharmaceuticals, INC. | $71.72 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $67.35 | 2019 | |
| Kci USA, INC. | $64.43 | 2021-2023 | Promogran Prisma, Activ.A.C. Ion Progress, 3m Cavilon |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $56.34 | 2022-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Paratek Pharmaceuticals, INC. | $52.52 | 2021-2022 | |
| Olympus America INC. | $28.48 | 2023 | Olympus |
| Organogenesis INC. | $24.18 | 2024 | |
| Melinta Therapeutics, LLC | $21.97 | 2019 | |
| Allergan, INC. | $21.06 | 2020 | |
| Conmed Corporation | $20.83 | 2023 | Airseal |
| Innocoll Pharmaceuticals Limited | $20.58 | 2021 | |
| Tetraphase Pharmaceuticals, INC. | $20.16 | 2020 | |
| Csl Behring | $20.00 | 2024 | Kcentra |
| Checkpoint Surgical, INC | $19.36 | 2021 | |
| Solventum Corporation | $19.32 | 2025 | Prevena, Activ.A.C. |
| Bioventus LLC | $18.17 | 2022 | |
| Shire North American Group INC | $18.06 | 2019 | |
| Urgo Medical North America, LLC | $16.10 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Reprise Biomedical, INC. | $14.65 | 2024 | Miro3d |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Simon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.